Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 08 tags : Bb-301 save search
Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022
Published: 2021-09-08 (Crawled : 12:00) - ir.benitec.com
BNTC | $4.79 -2.44% -2.51% 27K
|
Health Technology
|
| O: -1.53%
H: 2.34%
C: -1.82%
bb-301 biopharma phase 1 positive trial phase 1b phase 2b
Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
Published: 2021-09-08 (Crawled : 12:00) - ir.benitec.com
BNTC | $4.79 -2.44% -2.51% 27K
|
Health Technology
|
| O: -1.53%
H: 2.34%
C: -1.82%
bb-301 biopharma animals positive
Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
Published: 2021-09-08 (Crawled : 12:00) - ir.benitec.com
BNTC | $4.79 -2.44% -2.51% 27K
|
Health Technology
|
| O: -1.53%
H: 2.34%
C: -1.82%
bb-301 biopharma phase 1 trial phase 1b phase 2b designation
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.